DUBLIN--(BUSINESS WIRE)--The "Prenatal Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis and the looming economic recession, the Prenatal Diagnostics market worldwide will grow by a projected US$2.8 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 8.3%. Prenatal Diagnostics, one of the segments analyzed and sized in this study, is forecast to grow at over 8.3% and reach a market size of US$6.6 Billion by the end of the analysis period.
The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Prenatal Diagnostics market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.
As part of the new emerging geographic scenario, the United States is forecast to readjust to a 6.7% CAGR. Within Europe, Germany will add over US$85.2 Million to the region's size over the next 7 to 8 years. In addition, over US$81.7 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Prenatal Diagnostics segment will reach a market size of US$319.2 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Prenatal Diagnostics market.
Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 13.3% over the next couple of years and add approximately US$715.4 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Prenatal Diagnostics market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include, among others,
- ANGLE Plc
- Berry Genomics Co. Ltd.
- BGI Genomics
- F. Hoffmann-La Roche Ltd.
- Hologic Inc.
- Illumina Inc.
- Laboratory Corporation of America Holdings
- Lifecodexx AG
- Natera Inc.
- Quest Diagnostics Inc.
- Ravgen Inc.
- Sequenom Inc.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Prenatal Testing: An Introductory Prelude
- Recent Market Activity
- The Rationale for Prenatal Genetic Testing
- Steady Growth Projected Over the Coming Years for Prenatal Testing
- Developed Regions: Primary Revenue Contributors
- Fast Paced Growth Forecasts in Developing Regions
- Northbound Trajectory in Healthcare Spending Creates Conducive Environment
- Prevailing Economic Scenario Favors Increased Healthcare Spending
- Progressive Momentum in Med Tech Sector Generates Parallel Opportunities
- Global Competitor Market Shares
- Prenatal Diagnostics Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Non-Invasive Prenatal Testing (NIPT) Transforms Prenatal Testing Landscape
- Major Factors Influencing Penetration of NIPT
- NIPT Eliminates Risks & Uncertainty of Conventional Procedures
- Replacing Screening Tests - A More Conceivable Change through NIPT
- Diversity in NIPT Usage on the Cards
- Benefits Outweigh Snags in NIPT Tests
- Whole Genome Sequencing Technology in NIPT
- DNA - More Ideal Target for NIPT Analysis than Whole Cells
- Conventional Invasive Techniques Loose Sheen
- Chromosomal Abnormalities Lead the Prenatal Testing Space
- Chromosomal Abnormalities - A Substantial Economic Burden
- List of Genetic Disorders by Event, Genetic Manifestation and Prevalence
- Significant Opportunities in Down's Syndrome Testing
- List of Select Screening Tests Available for T21 Screening and Confirmation
- Beyond Down's Syndrome - Need to Test Additional Targets Crucial
- Trisomy 18 or Edward's Syndrome
- Trisomy 13 or Patau Syndrome
- Cystic Fibrosis Screening and Diagnosis
- Cystic Fibrosis Screening Market - Highly Fragmented
- ACOG and ACGM Recommendations Boost Demand for Prenatal CF Testing
- Prenatal Testing Crucial to Detect Risk of Huntington's Disease
- Increasing Congenital Disorder Incidence - Key Driver for Prenatal Diagnostics
- Prenatal Testing - Effective Way of Alleviating Syphilis Related Deaths and Stillbirths
- Molecular Diagnostics Widen Scope & Span of Prenatal Testing
- NGS & MPS - Enabling Shorter Time to Test Results
- Microarray-Based Prenatal Testing Gathers Steam
- Sequencing in Prenatal Testing - A Potential High Growth Market
- Ultrasound - An Indispensable Combination with Blood Based Screening Tests
- New Sub-Targets on the Anvil for Ultrasound-Based Screening
- Counseling - An Imperative Measure Before and After Prenatal Testing
- Role of Prenatal Testing in Managing Preterm Births
- Lower Sensitivity & Specificity of Existing Tests - A Case for New Tests on the Anvil
- High Sensitivity Serum Tests May Not Have Many Takers
- Ballooning Global Female Population Offers Increased Growth Opportunities
- Issues & Challenges
- Prenatal Diagnostics: Treading Sensitive Ethical Issues
- Controversy Related to "Incidental Findings" of Prenatal Tests
- Opposition to NIPT Technique - A Significant Hurdle to Adoption
- Unresolved Issues Hamper Widespread Testing for Monogenetic Disease
- Dearth of Genetic Counselors - A Major Hurdle for Genetic Testing
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
Total Companies Profiled: 43
For more information about this report visit https://www.researchandmarkets.com/r/c8qcxh
